Information
-
Trademark
-
86577541
-
Serial Number
86577541
-
Registration Number
5239010
-
International Classifications
-
Filing Date
March 26, 2015
9 years ago
-
Registration Date
July 11, 2017
7 years ago
-
Transaction Date
July 05, 2024
2 months ago
-
Status Date
January 02, 2024
8 months ago
-
Published for Opposition Date
April 25, 2017
7 years ago
-
Location Date
January 02, 2024
8 months ago
-
Status Code
705
-
Employee Name
HUNT, LEE B
-
Attorney Docket Number
18634-570951
Attorney Name
Rebecca Liebowitz
Law Office Assigned Location Code
M60
-
Owners
Mark Drawing Code
4
Mark Identification
HEPTARES
Case File Statements
- GS0051: [ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
- TR0010: The wording "HEPTARES" has no meaning in a foreign language.
- GS0011: [ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
- GS0441: Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
- GS0421: Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services
Case File Event Statements
-
6/1/2015 - 9 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
3/30/2015 - 9 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/4/2015 - 9 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
5/27/2015 - 9 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
6/5/2015 - 9 years ago
5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
6/29/2015 - 9 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/12/2015 - 9 years ago
7 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/12/2015 - 9 years ago
8 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/12/2015 - 9 years ago
9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/8/2016 - 8 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
1/15/2016 - 8 years ago
11 - ASSIGNED TO LIE
Type: ALIE
-
1/20/2016 - 8 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/20/2016 - 8 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/20/2016 - 8 years ago
14 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Type: NAUD
-
1/20/2016 - 8 years ago
15 - NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Type: GAUD
-
1/20/2016 - 8 years ago
16 - NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Type: GAUN
-
2/16/2016 - 8 years ago
17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/16/2016 - 8 years ago
18 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/16/2016 - 8 years ago
19 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/8/2016 - 8 years ago
20 - FINAL REFUSAL WRITTEN
Type: CNFR
-
3/8/2016 - 8 years ago
21 - FINAL REFUSAL E-MAILED
Type: GNFR
-
3/8/2016 - 8 years ago
22 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
6/15/2016 - 8 years ago
23 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
6/15/2016 - 8 years ago
24 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/15/2016 - 8 years ago
25 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/7/2016 - 8 years ago
26 - SUBSEQUENT FINAL REFUSAL WRITTEN
Type: CFRC
-
7/7/2016 - 8 years ago
27 - SUBSEQUENT FINAL EMAILED
Type: GNSF
-
7/7/2016 - 8 years ago
28 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Type: GNS1
-
8/5/2016 - 8 years ago
29 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/5/2016 - 8 years ago
30 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
8/5/2016 - 8 years ago
31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/1/2017 - 7 years ago
32 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/3/2017 - 7 years ago
33 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/3/2017 - 7 years ago
34 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/10/2017 - 7 years ago
35 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/17/2017 - 7 years ago
36 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
4/5/2017 - 7 years ago
37 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/25/2017 - 7 years ago
38 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/25/2017 - 7 years ago
39 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/11/2017 - 7 years ago
40 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
10/30/2018 - 5 years ago
41 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
10/30/2018 - 5 years ago
42 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
5/6/2020 - 4 years ago
43 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
7/11/2022 - 2 years ago
44 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
7/10/2023 - a year ago
45 - TEAS SECTION 8 & 15 RECEIVED
Type: E815
-
1/2/2024 - 8 months ago
46 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
1/2/2024 - 8 months ago
47 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Type: C15P
-
1/2/2024 - 8 months ago
48 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Type: NA85
-
7/4/2024 - 2 months ago
49 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN